Mithra and Searchlight sign LSA for Myring™ in Canada

  • Mithra grants exclusive license for vaginal contraceptive ring to Searchlight Pharma for commercialization in Canada
  • With Mithra’s two leading products Myring™ and Estelle®, Searchlight Pharma aims to further expand its growing footprint in Women’s Health

Liege, Belgium, 16 December 2019 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces that it has entered into an exclusive license and supply agreement with Searchlight Pharma (Searchlight) for the commercialization of its hormonal contraceptive ring Myring™ in Canada.